Canadian Critical Care Trials Group

Canadian Critical Care Trials Group
Name	Canadian Critical Care Trials Group
Founded	0 1989
Focus	Critical care medicine, clinical trials, knowledge translation
Headquarters	Canada
Key people	D. James (Jim) K. Cooper, John C. Marshall, Deborah J. Cook
Website	http://www.ccctg.ca

Canadian Critical Care Trials Group. It is a collaborative national research network dedicated to advancing evidence-based medicine in intensive care units across Canada and internationally. Founded in 1989, the group designs and conducts large-scale, pragmatic randomized controlled trials to address fundamental questions in the management of critically ill patients. Its work has directly influenced global clinical practice guidelines and improved standards of care in critical care medicine.

History and formation

The group was established in 1989 by a consortium of pioneering intensivists and researchers, including founding chair D. James (Jim) K. Cooper. Its formation was driven by a recognized need for high-quality, multi-center trials to inform practice in the nascent field of critical care medicine. Early meetings, often held in conjunction with the Canadian Critical Care Society, solidified a culture of collaboration over competition among academic health science centres. The group's first major trial, investigating corticosteroids in septic shock, set a precedent for its methodological rigor and national scope, establishing a framework that attracted subsequent leaders like John C. Marshall and Deborah J. Cook.

Major clinical trials

The group has executed numerous landmark studies that have reshaped critical care paradigms. The Transfusion Requirements in Critical Care (TRICC) trial, led by Paul C. Hébert, fundamentally altered blood transfusion practices worldwide. The PROTECT trial, investigating heparin for deep vein thrombosis prophylaxis, and the OSCILLATE trial, evaluating high-frequency oscillatory ventilation in acute respiratory distress syndrome, are other cornerstone studies. Landmark investigations into nutrition strategies, sedation protocols, and ventilator-associated pneumonia prevention, such as the SSC-endorsed PROWESS-SHOCK trial, further exemplify its broad portfolio.

Research focus and methodology

The group's research prioritizes patient-centered, pragmatic questions with direct applicability to bedside care in the ICU. Its methodology emphasizes large sample sizes, streamlined protocols suitable for busy critical care units, and clinically relevant primary outcome measures like mortality and ventilator-free days. A hallmark is its integrated knowledge translation strategy, engaging clinical nurse specialists, respiratory therapists, and pharmacists from inception. This approach ensures feasibility and accelerates the adoption of results into guidelines from bodies like the Surviving Sepsis Campaign and the American Thoracic Society.

Impact on critical care practice

The group's trials have directly transformed standard of care in intensive care medicine globally. The TRICC trial's findings led to widespread adoption of a restrictive transfusion strategy, conserving blood bank resources and improving patient safety. Its work on sedation and delirium, including the eCASH concept, has been incorporated into protocols from the Society of Critical Care Medicine. Studies on enteral nutrition and stress ulcer prophylaxis have refined supportive care bundles. This evidence has been codified in international guidelines, influencing practice in organizations like the National Health Service and the European Society of Intensive Care Medicine.

Organizational structure and funding

The group operates as an investigator-led, not-for-profit consortium with a central coordinating centre, historically based at St. Michael's Hospital in Toronto. Governance is provided by a steering committee of senior investigators from major university-affiliated hospitals across Canada. Core funding has been secured through peer-reviewed grants from the Canadian Institutes of Health Research and the Heart and Stroke Foundation of Canada. Individual trials receive additional support from federal agencies like the Department of National Defence and partnerships with industry, all managed under strict academic independence agreements.

Collaborations and networks

The group maintains extensive national and international partnerships to amplify its research impact. It is a founding member of the International Forum for Acute Care Trialists, collaborating with networks like the Australian and New Zealand Intensive Care Society Clinical Trials Group and the United Kingdom Critical Care Research Group. Within North America, it works closely with the National Institutes of Health-funded PETAL Network and the Canadian Institutes of Health Research-supported Strategy for Patient-Oriented Research. These collaborations enable global mega-trials, sharing of clinical research coordinator expertise, and harmonization of data management systems across continents.

Category:Medical and health organizations based in Canada Category:Medical research organizations Category:Critical care medicine